Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8741533 | Osteoarthritis and Cartilage | 2018 | 33 Pages |
Abstract
Chronic TLR4 inhibition decreased behavioral signs of LBP, pain-related neuroplasticity and disc inflammation in SPARC-null mice. TAK-242 inhibits TLR4 activation within discs, as evidenced by decreases in cytokine release. Therefore, TLRs are potential therapeutic targets to slow disc degeneration and reduce pain.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Emerson Krock, Magali Millecamps, J. Brooke Currie, Laura S. Stone, Lisbet Haglund,